Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pelvic Neoplasms × Vorinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 26 Lymphoma 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Multiple Myeloma 20 Lymphoma, Large B-Cell, Diffuse 20 Carcinoma, Non-Small-Cell Lung 18 Breast Neoplasms 18 Lymphoma, Non-Hodgkin 16 Lymphoma, Follicular 14 Hodgkin Disease 14 Lymphoma, Mantle-Cell 13 Lymphoma, T-Cell, Cutaneous 12 Leukemia, Lymphocytic, Chronic, B-Cell 11 Glioblastoma 11 Brain Neoplasms 11 Recurrence 10 Myelodysplastic Syndromes 10 Mycosis Fungoides 10 Lymphoma, B-Cell, Marginal Zone 10 Burkitt Lymphoma 10 Neuroblastoma 9 Congenital Abnormalities 9 Sezary Syndrome 8 Neoplasms 8 Leukemia 8 Prostatic Neoplasms 7 Neoplasms, Plasma Cell 7 Lymphoma, Large-Cell, Anaplastic 7 Lung Neoplasms 7 Leukemia, Myelomonocytic, Chronic 7

Interventions

Specimen Handling 2 Radiotherapy 2 Iohexol 2 Gemcitabine 2 spartalizumab 1 sodium thiosulfate 1 liposomal doxorubicin 1 X-Rays 1 Vorinostat 1 Surgical Procedures, Operative 1 Sunitinib 1 Solutions 1 Saline Solution 1 Re-Irradiation 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Probiotics 1 Platinum 1 Particle Accelerators 1 Pafolacianine 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lidocaine 1 Ketamine 1 Injections 1 Immunotherapy, Adoptive 1 Hyperthermic Intraperitoneal Chemotherapy 1 FS 069 1 Embolization, Therapeutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455351 2023-05-08

PRAVO

Oslo University Hospital

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡